Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: de Muga, Silviaa; e; | Hernández, Silviab; ; * | Salido, Martac | Lorenzo, Martaa | Agell, Laiaa | Juanpere, Núriaa | Lorente, José A.d; f | Serrano, Sergioa; f | Lloreta, Josepa; b
Affiliations: [a] Department of Pathology, Hospital del Mar-Parc de Salut Mar-IMIM, Barcelona, Spain | [b] Department of Health and Experimental Sciences, Universitat Pompeu Fabra, Barcelona, Spain | [c] Molecular Cytogenetics Laboratory, Department of Pathology, Hospital del Mar-Parc de Salut Mar-IMIM, Barcelona, Spain | [d] Department of Urology, Hospital del Mar-Parc de Salut Mar-IMIM, Barcelona, Spain | [e] Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain | [f] Department of Morphologic Sciences, Autonomous University of Barcelona, Barcelona, Spain
Correspondence: [*] Corresponding author: Silvia Hernández, Department of Health and Experimental Sciences, Universitat Pompeu Fabra, Passeig Maritim 25-29, 08003-Barcelona, Spain. Tel.: +34 93 248 30 31; Fax: +34 93 248 31 31; E-mail: silvia.hernandez@upf.edu.
Note: [1] The two first authors have contributed equally to this paper.
Abstract: The TMPRSS2-ERG fusion has been reported in 42 to 78% of prostate tumors. More than 90% of ERG-overexpressing tumors harbor the fusion. The relationship between the TMPRSS2-ERG fusion and prognosis is controversial. Different studies have suggested an association between CXCR4 and ERG overexpression resulting from the TMPRSS2-ERG rearrangement. The aim of this study was to investigate the relationship between CXCR4 expression, TMPRSS2-ERG fusion and Gleason grade in prostate cancer. TMPRSS2-ERG rearrangement was investigated by FISH (n=44), ERG protein by IHC (n=84), and CXCR4 by quantitative RT-PCR (n=44). TMPRSS2-ERG rearrangement and ERG protein expression were present in almost 50% of the cases, without statistical differences between the different Gleason score groups. There was a very high concordance between FISH and IHC techniques (Kappa Index=0.954). Seventy percent of Gleason ⩾ 8 prostate tumors overexpressed CXCR4 mRNA, and the difference in CXCR4 expression with Gleason < 8 cases was statistically significant (p=0.009). There was no association between ERG protein and CXCR4 mRNA expression. In conclusion, our results reveal for the first time that CXCR4 overexpression is associated with high Gleason score prostate tumors, but that it is independent of the TMPRSS2-ERG rearrangement.
Keywords: CXCR4, TMPRSS2, ERG, rearrangement, overexpression, prostate cancer
DOI: 10.3233/CBM-2012-00288
Journal: Cancer Biomarkers, vol. 12, no. 1, pp. 21-30, 2013
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl